The global atherectomy devices market is expected to reach USD 894.69 million by 2025. The demand for atherectomy devices market is anticipated to boost over the forecast period due to rapidly rising incidence of target diseases such as peripheral artery disease.
New technologies and product approvals are expected to boost the market for orbital and laser atherectomy devices over the forecast period. For instance, in July 2016, Cardiovascular Systems Inc. submitted an application for approval to Pharmaceuticals and Medical Devices Agency (PMDA), Japan's regulatory agency for pharmaceuticals and medical devices. The company intends to launch Diamondback 360 Coronary OAS Micro Crown in the region and is looking for potential distributors. This would be the company's first international market entry and the approval procedure is yet to be completed.
Geographically, North America held the largest market share in 2015 and is expected to maintain its position during the forecast period. A high prevalence of Peripheral Artery Diseases (PAD) in this region is one of the key reasons for high demand of atherectomy. Almost 8.5 million people suffer from PAD in the U.S., resulting in an annual economic burden of nearly USD 160 million.
- Boston Scientific Corporation
- Cardiovascular Systems Inc.
- Medtronic plc.
- VOLCANO CORPORATION
- Avinger Inc.
- Bayer AG
- Straub Medical AG
- ST. JUDE MEDICAL
- BARD Peripheral Vascular
- Cardinal Health (Cordis)
Terumo Medical Corporation
Key Topics Covered:
1 Research Methodology
2 Executive Summary
3 Market Snapshot
4 Atherectomy Devices Market Variables, Trends & Scope
5 Atherectomy Devices: Type Estimates & Trend Analysis
6 Atherectomy Devices: Regional Estimates & Trend Analysis, by Type
7 Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/3v84k9/atherectomy